home / stock / hsdt / hsdt news


HSDT News and Press, Helius Medical Technologies Inc.

Stock Information

Company Name: Helius Medical Technologies Inc.
Stock Symbol: HSDT
Market: NASDAQ
Website: heliusmedical.com

Menu

HSDT HSDT Quote HSDT Short HSDT News HSDT Articles HSDT Message Board
Get HSDT Alerts

News, Short Squeeze, Breakout and More Instantly...

HSDT - 7 F-Rated Growth Stocks to Avoid Right Now: June 2024

2024-06-28 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips When does a growth stock become one of the top growth stocks to avoid? It sounds like the beginning of a riddle or a bad joke, but the answer is obvious – it’s when the st...

HSDT - Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke

-- Inclusion of the top neurorehabilitation centers REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions completes site participation enrollment for the U.S. registrational program in stroke -- -- In Canada, an additional study on the use of Portable Neu...

HSDT - MicroCap Rodeo's Spring into Summer Conference, June 6th 2024 - 25 Presenting Companies

NEW YORK, NY / ACCESSWIRE / June 6, 2024 / Today the MicroCap Rodeo - Spring into Summer will take place in-person on Thursday, June 6th, 2024 and host the executive management teams of 25 microcap companies. The conference will be held live at Convene NYC, with company presentations from begin...

HSDT - Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference

NEWTOWN, PA / ACCESSWIRE / May 31, 2024 / Helius Medical Technologies, Inc., (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that it will participate in the Spring Mic...

HSDT - Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier

-- Reimbursement at $23,900, slightly below list price -- -- Represents a significant milestone toward increasing accessibility of PoNS -- NEWTOWN, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Comp...

HSDT - Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

NEWTOWN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, will exhibit for the third...

HSDT - Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

-- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance impairment due to multiple sclerosis (MS) access to the only portable neurostimulation therapy with the potential to generate neuroplasticity -- NEWTOWN, Pa., May 20, 2024 (GLOBE NEWSWI...

HSDT - Helius Medical Technologies, Inc. (HSDT) Q1 2024 Earnings Call Transcript

2024-05-13 19:21:06 ET Helius Medical Technologies, Inc. (HSDT) Q1 2024 Results Conference Call May 13, 2024 04:30 PM ET Company Participants Michelle Bilski - Investor Relations-In-Site Communications Dane Andreeff - President and Chief Executive Officer Jeff Ma...

HSDT - Helius Medical Technologies GAAP EPS of -$3.08, revenue of $0.14M

2024-05-13 17:29:53 ET More on Helius Medical Technologies Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript Helius Medical Technologies raises $6.4M via equity offering Read the full article on Seeking Alpha For further details see: ...

HSDT - Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

NEWTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for...

Next 10